5VP1
Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders
History
Please read more about PDB versioning on our help page.
| Version | Date | Type | |
| 1-0 | 2017-12-27 | Initial release | No files available. |
| 1-1 | 2018-05-23 | Data collection, Structure summary | No files available. |
| 1-2 | 2024-03-13 | Data collection, Database references, Derived calculations, Refinement description |
